Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003077518 | SCV003462249 | likely benign | Nemaline myopathy 2 | 2023-09-03 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004960986 | SCV005451865 | uncertain significance | Inborn genetic diseases | 2024-09-08 | criteria provided, single submitter | clinical testing | The c.4982A>C (p.D1661A) alteration is located in exon 41 (coding exon 39) of the NEB gene. This alteration results from a A to C substitution at nucleotide position 4982, causing the aspartic acid (D) at amino acid position 1661 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |